The duration of an HIV infection course and its influencing factors


Cite item

Full Text

Abstract

AIM. To study the duration of the natural course of HIV infection and to identify its influencing factors. MATERIALS AND METHODS. 938 outpatient case histories of adult HIV-positive patients registered at the dispensary and the data of 3403 AIDS patients registered in the computer base, including those on 2588 dead people, were retrospectively analyzed. Kaplan-Meier survival analysis and Cox regression model were used. Gender, age, and route of infection were regarded as potential factors influencing the natural course of HIV infection. RESULTS. In Russia before the mass use of antiretroviral therapy (ART), the median survival from infection to death in the HIV-infected was 11.8 years; that from infection to establishment of AIDS was 11.6 years; the life expectancy following its diagnosis was 1.9 months. Patient age was a main factor influencing the course of HIV infection: in persons who had been infected with HIV at an age of over 35 years, lower CD4 lymphocyte counts and clinical progression occurred more rapidly than in those infected at a younger age. Less than 50% of the patients needed ART 5 years after HIV infection. CONCLUSION. An HIV-infected patient without ART survives almost twice less. It is necessary to detect HIV infection as early as possible and to regularly follow up patients regardless of the duration of infection in order to timely initiate its treatment.

About the authors

A V Pokrovskaia

ФБУН "Центральный НИИ эпидемиологии" Роспотребнадзора, Москва

Email: pokrovskaya_av@mail.ru

A A Popova

ФБУН "Центральный НИИ эпидемиологии" Роспотребнадзора, Москва

N N Ladnaia

ФБУН "Центральный НИИ эпидемиологии" Роспотребнадзора, Москва

O G Iurin

ФБУН "Центральный НИИ эпидемиологии" Роспотребнадзора, Москва

References

  1. Щербакова Е. Ожидаемая продолжительность жизни увеличится с 65 до 75 лет. Демоскоп Weekly 6-19 февраля 2006; 233-234: www.demoscop.ru
  2. Покровская А.В. Факторы, влияющие на течение ВИЧ-инфекциии. Эпидемиол и инфекц бол 2010; 3: 60-64.
  3. Qu W., Robinson M., Zhang F. Factors influencing the natural history of HIV-1 infection. Chinese Med J 2008; 121 (24): 2613-2621.
  4. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Lancet 2000; 355 (9210): 1131-1137.
  5. Jaffar S., Grant A.D., Whitworth J. et al. The natural of HIV-1 and HIV-2 infections in adult in Africa: a literature review. Bul World Health Organization 2004; 82 (6): 462-469.
  6. UK Register of HIV Seroconverters Steering Committee. The AIDS incubation period in the UK estimated from a national register of HIV seroconverters. AIDS 1998; 12: 659-667.
  7. Morgan D., Mahe C., Mayanja B. et al. HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? AIDS 2002; 16 (4): 597-603.
  8. Schneider M., Zwahlen M., Egger M. Natural history and mortality in HIV-positive individuals living in resource-poor settings: A literature review. UNAIDS Obligation HQ/03/463871, Bern, June 2004.
  9. Vergis E.N., Mellors J.W. Natural history of HIV-1 infection. Infect Dis Clin North Am 2000; 14: 809-825.
  10. Lohse N., Hansen A.B., Pedersen G. Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med 2007; 146 (2): 87-95.
  11. Лебедев П.В. Современные тенденции распространения и медико-социальная значимость ВИЧ-инфекции в Краснодарском крае: Дис. ... канд. мед. наук. Краснодар 2008; 160.
  12. ВИЧ-инфекция и СПИД: национальное руководство. Под ред. В.В. Покровского. М: ГЭОТАР-Медиа; 2013.
  13. Покровский В.В., Юрин О.Г., Кравченко А.А. и др. Протоколы диспансерного наблюдения и лечения больных ВИЧ-инфекцией. Эпидемиол. инфекц. болезни. Акт вопр 2013; 6: 1-32.

Copyright (c) 2014 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies